cbd dyskinesia

Cbd dyskinesia

People with dyskinetic CP suffer from uncontrolled movements. They may have difficulty with everyday activities such as walking, eating, and talking. People with dyskinetic CP may also suffer from jerky or writhing movements, which can vary from fast to slow.

THC is the most abundant phytocannabinoid in the cannabis plant and is responsible for its characteristic ‘high.’ THC could provide effective relief from pain and spasticity, improve mood, and aid sleep.

Tardive Dyskinesia

Although cannabis can cause some side effects, these are usually mild and short-lived. Therefore, it should be safe to try marijuana for dyskinesia, but you should always check with your physician first.

Tardive dyskinesia is also a side effect of medication, this time of neuroleptic (antipsychotic) drugs. These drugs are used to treat disorders such as psychosis and schizophrenia. Tardive dyskinesia is a common side effect of neuroleptic medications. According to one source, an estimated 16–50% of people who use neuroleptic drugs are affected.

Cerebral Palsy Dyskinesia

The cannabinoids found in marijuana could help to relieve dyskinesia in several different ways. Over 100 phytocannabinoids are identified to date. However, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are by far the most widely researched.

The concern was that starting levodopa treatment early in one’s treatment would increase the risk of dyskinesia. I decided to continue using levodopa since it was providing me with much-needed relief from my symptoms.

According to Rachel Dolhun, MD Vice President, Medical Communications at the Michael J Fox Foundation, “The work to date on marijuana and cannabinoids has given promising but conflicting signals on potential benefit for motor and non-motor symptoms as well as levodopa-induced dyskinesia. This therapy may represent a future treatment option for PD, but the correct dose and formulation are not clear, full side effects and drug interactions are unknown, and benefits have not been rigorously determined.” 1

Trying different medications

The medication most people with Parkinson’s end up taking at some point is levodopa, which is the gold standard for treating Parkinson’s. It was developed in the late 60s. It is sometimes used for diagnostic purposes.

CBD for my symptoms

CBD can be expensive and isn’t covered by insurance. The FDA has not approved medical marijuana and classifies it as a Schedule 1 drug which is a drug that has been found to have no acceptable medical use and a high potential for abuse.

Cannabis has been used for many medicinal purposes, including management of spasms, dystonia, and dyskinesias, with variable success. Its use for tetanus was described in the second century BCE, but the literature continues to include more case reports and surveys of its beneficial effects in managing symptoms of hyperkinetic movement disorders than randomized controlled trials, making evidence-based recommendations difficult. This paper reviews clinical research using various formulations of cannabis (botanical products, oral preparations containing ∆ 9 -tetrahydrocannabinol and/or cannabidiol) and currently available preparations in the USA (nabilone and dronabinol). This has been expanded from a recent systematic review of cannabis use in several neurologic conditions to include case reports and case series and results of anonymous surveys of patients using cannabis outside of medical settings, with the original evidence classifications marked for those papers that followed research protocols. Despite overlap in some patients, dyskinesias will be treated separately from dystonia and chorea; benefit was not established beyond individual patients for these conditions. Tics, usually due to Tourettes, did respond to cannabis preparations. Side effects reported in the trials will be reviewed but those due to recreational use, including the dystonia that can be secondary to synthetic marijuana preparations, are outside the scope of this paper.

Electronic supplementary material

Dystonia involves overactivity of muscles required for normal movement, with extra force or activation of nearby but unnecessary muscles, including those that should be turned off to facilitate movement, and is often painful in addition to interfering with function. It can be primary, as in torticollis and blepharospasm/orofacial dyskinesias or dystonias (Meige syndrome) or as part of another condition such as HD and tardive dyskinesia after dopa-blocking drugs. The globus pallidus and substantia nigra pars reticularis contain CB1R, with cannabinoids acting as neuromodulators and enhancing GABA release and reducing its reuptake [5].


The plethora of endocannabinoid receptors in the basal ganglia, especially the globus pallidus interna, pars reticulata, and cerebellum indicate they must be playing a role in regulating tone and motor function through the effect of the endogenous cannabinoid ligand, arachidonylethanolamide (anadamide), on modulation of GABA transmission [12]. Many studies have been done with primate or rat models to determine if cannabinoid agonists or antagonists could act to suppress dyskinesias without exacerbating hypokinesis; however, translation to patients has proved difficult.